MARKET

CRY

CRY

CryoLife
NYSE

Real-time Quotes | Nasdaq Last Sale

23.94
-0.69
-2.80%
Closed 16:31 09/17 EDT
OPEN
24.65
PREV CLOSE
24.63
HIGH
24.65
LOW
23.70
VOLUME
613.45K
TURNOVER
--
52 WEEK HIGH
32.34
52 WEEK LOW
16.60
MARKET CAP
940.99M
P/E (TTM)
-79.7468
1D
5D
1M
3M
1Y
5Y
Medical Adhesive Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2028
Research Nester has released a report titled " " which delivers detailed overview of the globalmedical adhesive market in terms of market segmentation by product type, application, and by region.
AmericaNewsHour · 3h ago
CryoLife to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
/PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Morgan Stanley 19 Annual Global Healthcare Conference on . The Company's virtual ...
PR Newswire - PRF · 08/31 20:25
BRIEF-CryoLife Files For Potential Mixed Shelf Offering Size Not Disclosed
reuters.com · 08/11 22:12
CryoLife to Participate in Upcoming Virtual Investor Conferences
/PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two upcoming virtual investor conferences.
PR Newswire - PRF · 08/02 20:30
Prosthetic Heart Valve Market Size 2021 By Trends Evaluation, Leading Players Updates, Consumer-Demand, Consumption, Recent Developments, Strategies, Market Impact and Forecast till 2027
The scope of the report includes a detailed study of global and regional markets for various Prosthetic Heart Valves Market with the reasons given for variations in the growth of the industry in certain regions.
Heraldkeepers · 07/30 18:54
What Type Of Shareholders Own The Most Number of CryoLife, Inc. (NYSE:CRY) Shares?
Every investor in CryoLife, Inc. ( NYSE:CRY ) should be aware of the most powerful shareholder groups. Institutions...
Simply Wall St. · 07/30 07:18
--Needham Adjusts CryoLife's Price Target to $39 From $38, Maintains Buy Rating
MT Newswires · 07/30 06:17
CryoLife (CRY) Reports Q2 Loss, Tops Revenue Estimates
Zacks.com · 07/29 23:15
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CRY. Analyze the recent business situations of CryoLife through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CRY stock price target is 34.19 with a high estimate of 39.00 and a low estimate of 30.75.
EPS
Institutional Holdings
Institutions: 195
Institutional Holdings: 35.32M
% Owned: 89.85%
Shares Outstanding: 39.31M
TypeInstitutionsShares
Increased
42
640.50K
New
16
353.15K
Decreased
46
1.18M
Sold Out
10
191.84K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.10%
Healthcare Equipment & Supplies
+0.65%
Key Executives
Chairman/President/Chief Executive Officer/Director
James Mackin
Chief Financial Officer/Chief Operating Officer/Executive Vice President
D. Ashley Lee
Senior Vice President/Chief Compliance Officer/General Counsel/Secretary
Jean Holloway
Senior Vice President/Director of Sales/Director of Marketing
John Davis
Chief Accounting Officer/Vice President
Amy Horton
Vice President - Operations
Dennis Maier
Vice President/Director of Human Resources
Matthew Getz
Vice President
F. Peter Barthold
Vice President
Scott Capps
Independent Director
Thomas Ackerman
Independent Director
Daniel Bevevino
Independent Director
Marna Borgstrom
Independent Director
James Bullock
Independent Director
Jeffrey Burbank
Independent Director
Jon Salveson
Declaration Date
Dividend Per Share
Ex-Div Date
10/23/2015
Dividend USD 0.03
12/09/2015
07/22/2015
Dividend USD 0.03
09/09/2015
05/22/2015
Dividend USD 0.03
06/10/2015
02/13/2015
Dividend USD 0.03
03/11/2015
10/23/2014
Dividend USD 0.03
12/10/2014
07/30/2014
Dividend USD 0.03
09/10/2014
05/23/2014
Dividend USD 0.03
06/11/2014
02/20/2014
Dividend USD 0.027
03/12/2014
11/21/2013
Dividend USD 0.027
12/11/2013
08/21/2013
Dividend USD 0.027
09/11/2013
05/28/2013
Dividend USD 0.027
06/12/2013
About CRY
CryoLife, Inc. (CryoLife), is a medical device company. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as Surgical Sealants, BioGlue products, JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PhotoFix, and NEXUS. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues.

Webull offers kinds of Cryolife Inc stock information, including NYSE:CRY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CRY stock methods without spending real money on the virtual paper trading platform.